Godavari Biorefineries Limited — Results, 26-05-2025: Integrated Filing- Financial

Godavari Biorefineries Ltd has announced a board meeting to consider the financial results for the quarter and half-year.

1) Revenue Performance:

Consolidated total income for FY25 stood at ₹1,886.91 Cr, up 11% YoY from ₹1,701.06 Cr in FY24. Growth was led by strong contributions from Sugar (₹1,312.57 Cr), Co-generation, Bio-based Chemicals, and Distillery segments. Q4 revenue jumped sequentially to ₹588.76 Cr from ₹450.83 Cr.

2) Profitability and EPS:

Net profit after tax surged to ₹710.28 Cr in FY25 versus ₹122.98 Cr in FY24, reflecting a sharp turnaround partly due to one-time deferred tax benefits. Basic EPS improved to ₹14.05 from a loss of ₹5.13. Operational leverage and tax benefits were key drivers behind profitability enhancement.

3) Operational Costs:

Cost of materials consumed reduced to ₹1,242.75 Cr from ₹1,533.15 Cr, aided by inventory reduction. Employee expenses and other operating costs saw marginal increases, while finance costs declined moderately to ₹7.18 Cr, supporting margin expansion.

4) Key Metrics:

Operating profit before interest nearly doubled to ₹1,055.84 Cr from ₹530.02 Cr, largely driven by Sugar and Bio-based Chemicals segments. Segment EBITDA margins improved, reflecting better efficiencies.

5) Balance Sheet / Cash Flow Health:

Consolidated borrowings declined significantly to ₹489.31 Cr from ₹654.06 Cr, supported by a ₹325 Cr fresh equity infusion via IPO aimed at reducing debt. Cash balances improved marginally, and capex stood at ₹71.6 Cr for the year, indicating measured expansion.

6) Management Commentary / Strategic Outlook:

The company’s successful IPO has strengthened the balance sheet by lowering interest burden. Management plans to focus on scaling Bio-based Chemicals and Distillery segments, while managing seasonality risks in Sugar. Deferred tax impact is one-time.

Final Takeaway:

Godavari Biorefineries shows robust operational and financial recovery, supported by deleveraging and efficiency gains. With growth momentum in bio-products and energy, it presents a compelling case for retail investors eyeing cyclical upside in the agri-processing sector.